Brokerages Expect Progenics Pharmaceuticals, Inc. (PGNX) Will Announce Earnings of -$0.18 Per Share


Equities research analysts expect Progenics Pharmaceuticals, Inc. to report earnings per share of for the current quarter, Zacks Investment Research reports. Two analysts have made estimates for Progenics Pharmaceuticals' earnings.



from Biotech News